Parkinson's disease other imaging findings

	Parkinson's disease Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Parkinson's disease from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Neurocognitive Disorder Due to Parkinson's Disease
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Parkinson's disease other imaging findings On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Parkinson's disease other imaging findings All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Parkinson's disease other imaging findings
CDC on Parkinson's disease other imaging findings
Parkinson's disease other imaging findings in the news
Blogs on Parkinson's disease other imaging findings
Directions to Hospitals Treating Parkinson's disease
Risk calculators and risk factors for Parkinson's disease other imaging findings

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

PET scan: In PET scan we can see that the uptake of [18F]-flurodopa tracer in reduce in the caudate and putamen in PD patients.^[1]

↑ Teune LK, Bartels AL, de Jong BM, Willemsen AT, Eshuis SA, de Vries JJ, van Oostrom JC, Leenders KL (October 2010). "Typical cerebral metabolic patterns in neurodegenerative brain diseases". Mov. Disord. 25 (14): 2395–404. doi:10.1002/mds.23291. PMID 20669302.